BamSEC and AlphaSense Join Forces
Learn More

MiNK Therapeutics Inc.

NASDAQ: INKT    
Share price (12/23/24): $0.49    
Market cap (12/23/24): $19.4 million

Material Contracts Filter

EX-10.1
from 10-Q 43 pages Stock Purchase Agreement
12/34/56
EX-10.18
from 10-K 8 pages Convertible Promissory Note Purchase Agreement
12/34/56
EX-10
from 10-K 33 pages Master Services Agreement
12/34/56
EX-10.1
from 10-Q 21 pages Amended and Restated Intercompany Services Agreement
12/34/56
EX-10.1
from 8-K 14 pages MiNK Therapeutics, Inc. Executive Change of Control Plan
12/34/56
EX-10.17
from 10-K 11 pages Contract of Employment
12/34/56
EX-10.16
from 10-K 19 pages Executive Employment Agreement
12/34/56
EX-10.20
from S-1/A 14 pages Indemnification Agreement
12/34/56
EX-10.11
from S-1/A 4 pages MiNK Therapeutics, Inc. 2021 Equity Incentive Plan Incentive Stock Option Agreement
12/34/56
EX-10.10
from S-1/A 4 pages MiNK Therapeutics, Inc. 2021 Equity Incentive Plan Non-Statutory Stock Option Agreement
12/34/56
EX-10.9
from S-1/A 4 pages MiNK Therapeutics, Inc. 2021 Equity Incentive Plan Restricted Stock Unit Agreement
12/34/56
EX-10.8
from S-1/A 7 pages MiNK Therapeutics, Inc. 2021 Cash Incentive Plan
12/34/56
EX-10.7
from S-1/A 12 pages MiNK Therapeutics, Inc. 2021 Employee Stock Purchase Plan
12/34/56
EX-10.6
from S-1/A 16 pages MiNK Therapeutics, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.4
from S-1/A 3 pages Amendment to Convertible Promissory Note
12/34/56
EX-10.17
from S-1 8 pages Agentus Therapeutics, Inc. 2018 Equity Incentive Plan Restricted Stock Agreement
12/34/56
EX-10.16
from S-1 1 page November 12, 2020 Patrick Jordan Dear Patrick
12/34/56
EX-10.15
from S-1 3 pages November 14, 2019 Dr. Walter Flamenbaum Dear Walter
12/34/56
EX-10.14
from S-1 9 pages Agentus Therapeutics, Inc. 2018 Equity Incentive Plan Incentive Stock Option Stock Option Agreement
12/34/56
EX-10.13
from S-1 8 pages Agentus Therapeutics, Inc. 2018 Equity Incentive Plan Non-Qualified Stock Option Stock Option Agreement
12/34/56